Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Neeland IJ, Linge J, Birkenfeld AL. Diabetes Obes Metab 2024;26 Suppl 4:16-27.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab 2024;26 Suppl 4:16-27.
PMID: 38937282